Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
1,303,324
-
Shares change
-
-55,452
-
Total reported value, excl. options
-
$1,614,012
-
Value change
-
-$228,188
-
Number of buys
-
18
-
Number of sells
-
-5
-
Price
-
$1.24
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2022
27 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q4 2022.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,303,324 shares
of 66,587,586 outstanding shares and own 1.96% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (634,444 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (193,682 shares), EDGEWOOD MANAGEMENT LLC (100,000 shares), RENAISSANCE TECHNOLOGIES LLC (73,696 shares), VANGUARD GROUP INC (43,795 shares), HRT FINANCIAL LP (42,277 shares), Ergoteles LLC (27,941 shares), BlackRock Inc. (24,552 shares), GEODE CAPITAL MANAGEMENT, LLC (22,463 shares), and JANE STREET GROUP, LLC (20,024 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.